Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

Cannabis-based oral spray could kill brain tumours, study to launch next year

August 3, 2021 Manufacturing and Production, Medical Communications, Research and Development

The NHS alongside cancer charities are set to launch a clinical trial to investigate the effects of a cannabis-based oral …
News
andrei_r_-_shutterstock_1935537274_720

Complix and Jiangsu Nhwa to collaborate on treatment of CNS Diseases

July 28, 2021 Research and Development

Complix has signed a global collaboration and license agreement with Jiangsu Nhwa Pharmaceutical Co, to develop Cell Penetrating Alphabodies (CPABs), …
News

US to ship nearly 10 million vaccine doses to Nigeria and South Africa

July 28, 2021 Research and Development

On Wednesday the US government will ship 4 million vaccine does to Nigeria and 5.66 million doses to South Africa. …
News

CanSino’s inhaled COVID vaccine performs well in early trials

July 28, 2021 Manufacturing and Production, Research and Development

Early-stage data, published in The Lancet on Monday, has shown CanSino Biologic’s inhaled COVID-19 vaccine was able to stimulate neutralising …
News

Biogen withdrew Aduhelm paper when asked for edits from JAMA

July 28, 2021 Research and Development

The makers of the controversial drug Aduhelm, Biogen, withdrew its paper that analysed the drug’s results that was submitted to …
News
astrazeneca_sign_sky

AstraZeneca & Regeneron to develop small molecule obesity treatment

July 28, 2021 Manufacturing and Production, Research and Development

AstraZeneca and Regeneron have announced a collaboration to research, develop and commercialise small molecule compounds directed against the GPR75 target …
News

BioNTech set to develop first mRNA malaria vaccine

July 27, 2021 Manufacturing and Production, Research and Development

Buliding on the success of its COVID-19 vaccine, BioNTech has announced the development of the first mRNA vaccine against malaria, …
News

Antibodies from Sinovac’s COVID-19 vaccine fade after 6 months, study finds

July 27, 2021 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

A Chinese laboratory study has found that antibodies from Sinovac Biotech’s COVID-19 vaccine drop below a key threshold around six …
News

Expansion for first FDA-approved video game for ADHD treatment

July 23, 2021 Medical Communications, Research and Development ADHD, FDA, US, digital therapeutics, technology

Akili Interactive has announced the expansion of its prescription video game treatment, EndeavorRx, with the addition of new gaming features …
News
cdc-un8tv9pw2ik-unsplash_1

Two shots of Pfizer or AstraZeneca vaccine are effective against Delta variant

July 22, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

A new study has shown that two shots of either Pfizer or AstraZeneca’s COVID-19 vaccine are nearly as effective against …
News
roche__tree

Roche discussing potential Alzheimer’s treatment with FDA

July 22, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Roche is discussing its potential treatment, gantenerumab, for Alzheimer’s disease with the FDA as clinical trials proceed. Chief Executive Severin …
News

NICE approves treatment for rare bile duct cancer

July 22, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

NICE has approved Pemigatinib (Pemazyre) as first treatment for people with a rare form of bile duct cancer (cholangiocarcinoma). Pemigatinib, …
News
catalent

$100 million expansion planned for Catalent’s Italian vaccine plant

July 21, 2021 Manufacturing and Production, Research and Development

Contract drug manufacturer, Catalent, has announced its $100 million expansion plans for its site in Agnani, Italy, where it is …
News

Former FDA adviser calls for further investigation into Alzheimer’s drug

July 21, 2021 Research and Development

A former FDA advisor who resigned after the controversial approval of Biogen’s Alzheimer’s drug has called for a wider probe …
News

Exscientia and Apeiron announce joint oncology venture

July 21, 2021 Research and Development

AI pharmatech company, Exscientia, has announced a collaboration with Shanghai-based GT Apeiron Therapeutics, which will focus on oncology. The strategic …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026